Post-Authorization Safety Study to Assess the Safety of Vimpat as add-on Therapy in Patients With Partial-onset Seizures

NCT00771927 · clinicaltrials.gov ↗

COMPLETED

Status

1005

Enrollment

INDUSTRY

Sponsor class

Conditions

Epilepsies, Partial

Interventions

DRUG: Lacosamide

Sponsor

UCB Pharma